These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10448301)
21. Structure and expression of the human FHIT gene in normal and tumor cells. Druck T; Hadaczek P; Fu TB; Ohta M; Siprashvili Z; Baffa R; Negrini M; Kastury K; Veronese ML; Rosen D; Rothstein J; McCue P; Cotticelli MG; Inoue H; Croce CM; Huebner K Cancer Res; 1997 Feb; 57(3):504-12. PubMed ID: 9012482 [TBL] [Abstract][Full Text] [Related]
22. fhit Alterations in endometrial carcinoma and hyperplasia. Ozaki K; Enomoto T; Yoshino K; Hongbo S; Nakamura T; Fujita M; Kuragaki C; Sakata M; Kurachi H; Murata Y Int J Cancer; 2000 Feb; 85(3):306-12. PubMed ID: 10652418 [TBL] [Abstract][Full Text] [Related]
24. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas. Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas. Luceri C; Guglielmi F; De Filippo C; Caderni G; Mini E; Biggeri A; Napoli C; Tonelli F; Cianchi F; Dolara P Scand J Gastroenterol; 2000 Jun; 35(6):637-41. PubMed ID: 10912665 [TBL] [Abstract][Full Text] [Related]
26. Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells. Carapeti M; Aguiar RC; Sill H; Goldman JM; Cross NC Br J Cancer; 1998 Sep; 78(5):601-5. PubMed ID: 9744498 [TBL] [Abstract][Full Text] [Related]
27. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048 [TBL] [Abstract][Full Text] [Related]
28. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands. Nagel H; Laskawi R; Eiffert H; Schlott T Mol Pathol; 2003 Aug; 56(4):226-31. PubMed ID: 12890744 [TBL] [Abstract][Full Text] [Related]
29. Fhit expression is absent or reduced in a subset of primary head and neck cancer. Götte K; Hadaczek P; Coy JF; Wirtz HW; Riedel F; Neubauer J; Hörmann K Anticancer Res; 2000; 20(2A):1057-60. PubMed ID: 10810397 [TBL] [Abstract][Full Text] [Related]
30. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Hendricks DT; Taylor R; Reed M; Birrer MJ Cancer Res; 1997 Jun; 57(11):2112-5. PubMed ID: 9187105 [TBL] [Abstract][Full Text] [Related]
31. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
32. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines]. Lee SH; Kim HS Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704 [TBL] [Abstract][Full Text] [Related]
33. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma. Mandai M; Konishi I; Kuroda H; Nanbu K; Matsushita K; Yura Y; Hamid AA; Mori T Eur J Cancer; 1998 Apr; 34(5):745-9. PubMed ID: 9713284 [TBL] [Abstract][Full Text] [Related]
34. Homozygous deletions on the short arm of chromosome 3 in human oral squamous cell carcinomas. Uzawa N; Akanuma D; Negishi A; Iwaki H; Uzawa Y; Amagasa T; Yoshida MA Oral Oncol; 2001 Jun; 37(4):351-6. PubMed ID: 11337267 [TBL] [Abstract][Full Text] [Related]
35. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912 [TBL] [Abstract][Full Text] [Related]
36. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. Huiping C; Kristjansdottir S; Bergthorsson JT; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S Eur J Cancer; 2002 Mar; 38(5):728-35. PubMed ID: 11916557 [TBL] [Abstract][Full Text] [Related]
37. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration]. Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436 [TBL] [Abstract][Full Text] [Related]
38. Loss of FHIT expression in transitional cell carcinoma of the urinary bladder. Baffa R; Gomella LG; Vecchione A; Bassi P; Mimori K; Sedor J; Calviello CM; Gardiman M; Minimo C; Strup SE; McCue PA; Kovatich AJ; Pagano F; Huebner K; Croce CM Am J Pathol; 2000 Feb; 156(2):419-24. PubMed ID: 10666370 [TBL] [Abstract][Full Text] [Related]
39. Abnormal transcripts of FHIT gene in thyroid cancer. Chang TJ; Tsai TC; Wu YL; Yang HM; Chi CW; Yang AH; Lee CH Oncol Rep; 1998; 5(1):245-7. PubMed ID: 9458330 [TBL] [Abstract][Full Text] [Related]
40. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Yoshino K; Enomoto T; Nakamura T; Nakashima R; Wada H; Saitoh J; Noda K; Murata Y Int J Cancer; 1998 Apr; 76(2):176-81. PubMed ID: 9537577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]